Could a 'Use-When-Needed' inhaler help teens with asthma?

NCT ID NCT05689983

Ongoing Disease control Sponsor: Washington University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether a symptom-driven inhaler (budesonide/formoterol) works better for teens with asthma who often forget their daily maintenance inhalers. Researchers will compare adherence and asthma flare-ups between the standard daily inhaler plus rescue inhaler group and the symptom-driven group. The goal is to find a simpler approach that reduces hospitalizations and improves asthma control.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: budesonide/formoterol combination (Symbicort)
What this could lead to: If this approach works, it could offer a simpler, more effective way for teens to manage asthma without needing to remember daily inhalers.
What could go wrong: This is a small early-phase study with only 40 participants, so results may not apply to everyone. The symptom-driven strategy might not control asthma as well as daily maintenance therapy in some patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma childhood onset asthma Medication Adherence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA IN CHILDREN NONADHERENCE, MEDICATION

Contacts and locations

Locations

Washington University in St. Louis School of Medicine

St Louis, Missouri, 63110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.